This study will run for a maximum of 23 weeks, with visits required on a regular basis to The Charles Perkins Centre in Camperdown.
You will be medically supervised and there will be no costs involved. You will also be reimbursed for out of pocket expenses including travel
This study is being sponsored by Boehringer Ingelheim Pharmaceuticals, Inc and conducted at Boden Collaboration, The University of Sydney at the Charles Perkins Centre.
You may be eligible to participate in this study if you:
If you are interested in assisting with this important and exciting area of research, please contact the study facilitator: 8627 0101 or email@example.com
Please do leave a message with your name and contact details so we can return your call.